ConductScience.org, home

Trial · NCT07898657

Effect of an Electromagnetic Trainer on Gait and Balance Recovery After Stroke

NCT07898657, Not applicable, Recruiting, Karaganda Medical University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effect of an Electromagnetic Trainer on Gait and Balance Recovery After Stroke. Trials, record NCT07898657. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07898657

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effect of an Electromagnetic Trainer on Gait and Balance Recovery After Stroke
NCT number
NCT07898657
Status
Recruiting
Phases
Not applicable
Enrollment
80 participants, estimated
Lead sponsor
Karaganda Medical University
Conditions
Stroke
Interventions
Electromagnetic trainer, Standard medical rehabilitation
First posted
2026-10-27
Last updated
2026-10-27

Source ClinicalTrials.gov

Registered outcomes9

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryBerg Balance Scale (BBS)From baseline to the end of the rehabilitation course (approximately 10 days).Change in Berg Balance Scale (BBS) score from baseline to the end of rehabilitation. The BBS ranges from 0 to 56 points, with higher scores indicating better balance.
SecondaryChange in Tinetti Performance-Oriented Mobility Assessment (POMA) score from baseline to the end of rehabilitationBaseline to end of rehabilitation (approximately 10 days)
Change in Tinetti Performance-Oriented Mobility Assessment (POMA) score from baseline to the end of rehabilitation. The total score ranges from 0 to 28 points, with higher scores indicating better gait and balance performance.
SecondaryChange in Timed Up and Go (TUG) test time from baseline to the end of rehabilitationBaseline to end of rehabilitation (approximately 10 days)Change in the time required to complete the Timed Up and Go (TUG) test from baseline to the end of rehabilitation. Time is measured in seconds; lower times indicate better functional mobility.
SecondaryFugl-Meyer Assessment - Lower Extremity, Section E (0-28 points)Baseline to end of rehabilitation (approximately 10 days)Change in lower-extremity motor function assessed using Section E of the Fugl-Meyer Assessment. The score ranges from 0 to 28 points, with higher scores indicating better motor function.
SecondaryChange in National Institutes of Health Stroke Scale (NIHSS) score from baseline to the end of rehabilitationBaseline to end of rehabilitation (approximately 10 days)
Change in neurological impairment assessed using the National Institutes of Health Stroke Scale (NIHSS) from baseline to the end of rehabilitation. The total score ranges from 0 to 42 points, with higher scores indicating more severe neurological impairment.
SecondaryChange in Modified Ashworth Scale score from baseline to the end of rehabilitationAt rehabilitation admission (baseline) and at discharge from rehabilitation (approximately 10 days after baseline).
Change in muscle tone assessed using the Modified Ashworth Scale (MAS) from baseline to the end of rehabilitation. The scale grades resistance to passive movement from 0 to 4, with an additional grade of 1+, where applicable. Higher grades indicate greater muscle tone and spasticity.
SecondaryChange in Hospital Anxiety and Depression Scale (HADS) score from baseline to the end of rehabilitationBaseline to end of rehabilitation (approximately 10 days)
Change in anxiety and depressive symptoms assessed using the Hospital Anxiety and Depression Scale (HADS) from baseline to the end of rehabilitation. The scale consists of two subscales: anxiety (HADS-A) and depression (HADS-D), each ranging from 0 to 21 points. Higher scores indicate greater severity of anxiety or depressive symptoms.
SecondaryChange in Barthel Index score from baseline to the end of rehabilitationBaseline to end of rehabilitation (approximately 10 days)
Change in functional independence assessed using the Barthel Index from baseline to the end of rehabilitation. The total score ranges from 0 to 100 points, with higher scores indicating greater independence in activities of daily living.
OtherChange in lower limb joint range of motion from baseline to the end of rehabilitationBaseline to end of rehabilitation (approximately 10 days)Assessment of changes in range of motion of the lower limb joints using goniometry. Hip and knee flexion and extension, and ankle dorsiflexion and plantarflexion are measured in degrees.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07898657

GET https://conductscience.org/api/trials/v1/NCT07898657/registered